Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis

• David O'Sullivan ,

  Contributed equally to this work with: David O'Sullivan, Laura Green

  Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

  ⨯
• Laura Green ,

  Contributed equally to this work with: David O'Sullivan, Laura Green

  Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

  ⨯
• Sarrabeth Stone,

  Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

  ⨯
• Pirooz Zareie,

  Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

  ⨯
• Marie Kharkrang,

  Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

  ⨯
• Dahna Fong,

  Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

  ⨯
• Bronwen Connor,

  Affiliation Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

  ⨯
• Anne Camille La Flamme

  * E-mail: anne.laflamme@vuw.ac.nz

  Affiliations School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand, Malaghan Institute of Medical Research, Wellington, New Zealand

  ⨯